Abstract
Human beings are continuously exposed to various toxic substances throughout their lives, which affect their reproductive health and eventually the offspring they give birth to. Mainly, these toxins damage the heart and neurological development of the newborn, but most recently, they have begun to affect the musculoskeletal system as well. These toxins are usually present in food, pharmaceuticals, cosmetics, or even the polluted air that people breathe; as a result, the prevalence of birth defects is steadily rising. For this reason, it becomes a necessity to deploy a new set of assays to test for such toxins in industries to decrease the occurrence of developmental toxicity. These assays are exceedingly expensive when carried out conventionally using animal models or cells from such sources and have a lower predictive value due to the vast variation between animals and humans. To overcome such major problems, human pluripotent stem cells are now frequently used for these assays. These cells are easily available, are quickly generated from somatic cells (induce pluripotent stem cells), can be of human origin without harming people, and eliminate animal harm, which makes them the top choice of scientists for carrying out any in vitro developmental toxicity assays.
This chapter, therefore, provides an overview of several steps that can be used to predict a compound’s developmental toxicity by utilizing human pluripotent stem cells. Here, the easiest and most effective procedure has been outlined that can screen many compounds simultaneously.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kanno S, Okubo Y, Kageyama T, Yan L, Kitajima S, Fukuda J (2022) Establishment of a developmental toxicity assay based on human iPSC reporter to detect FGF signal disruption. iScience 25(2):103770. https://doi.org/10.1016/j.isci.2022.103770
Gupta PK (2020) Problem solving questions in toxicology. https://doi.org/10.1007/978-3-030-50409-0
Jamkhande PG, Chintawar KD, Chandak PG (2014) Teratogenicity: a mechanism based short review on common teratogenic agents. Asian Pac J Trop Dis 4(6):421–432. https://doi.org/10.1016/S2222-1808(14)60600-9
van Gelder MMHJ, van Rooij IALM, Miller RK, Zielhuis GA, de Jong-van den Berg LTW, Roeleveld N (2010) Teratogenic mechanisms of medical drugs. Hum Reprod Update 16(4):378–394. https://doi.org/10.1093/humupd/dmp052
Martin PL, Weinbauer GF (2010) Invited reviews: developmental toxicity testing of biopharmaceuticals in nonhuman primates: previous experience and future directions. Int J Toxicol 29(6):552–568. https://doi.org/10.1177/1091581810378896
Hansen DK, Inselman AL (2011) Applications of stem cells in developmental toxicology. Elsevier Inc. https://doi.org/10.1016/B978-0-12-382032-7.10058-X
Lee S, Bochanis A, Rasmussen TP (2019) Pluripotent cells for the assessment of chemically induced teratogenesis and developmental toxicology. Elsevier Inc. https://doi.org/10.1016/B978-0-12-816221-7.00007-0
Li S, Yang R, Yin N, Zhao M, Zhang S, Faiola F (2023) Developmental toxicity assessments for TBBPA and its commonly used analogs with a human embryonic stem cell liver differentiation model. Chemosphere 310:136924. https://doi.org/10.1016/j.chemosphere.2022.136924
Madrid JV, Sera SR, Sparks NRL, Zur Nieden NI (2018) Human pluripotent stem cells to assess developmental toxicity in the osteogenic lineage. Methods Mol Biol 1797:125–145
Lian X et al (2013) Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions. Nat Protoc 8(1):162–175. https://doi.org/10.1038/nprot.2012.150
Schwartz MP et al (2015) Human pluripotent stem cell-derived neural constructs for predicting neural toxicity. Proc Natl Acad Sci U S A 112(40):12516–12521. https://doi.org/10.1073/pnas.1516645112
Shinde V et al (2015) Human pluripotent stem cell based developmental toxicity assays for chemical safety screening and systems biology data generation. J Vis Exp 100:2015. https://doi.org/10.3791/52333
Kobolak J et al (2020) Human induced pluripotent stem cell-derived 3D-neurospheres are suitable for neurotoxicity screening. Cell 9(5). https://doi.org/10.3390/cells9051122
Mantziou V, Baillie-Benson P, Jaklin M, Kustermann S, Arias AM, Moris N (2021) In vitro teratogenicity testing using a 3D, embryo-like gastruloid system. Reprod Toxicol 105:72–90. https://doi.org/10.1016/j.reprotox.2021.08.003
Moris N et al (2020) Generating human gastruloids from human embryonic stem cells. Res Sq Protoc Exch:1–16, [Online]. Available: https://protocolexchange.researchsquare.com/article/pex-812/latest?utm_source=researcher_app&utm_medium=referral&utm_campaign=RESR_MRKT_Researcher_inbound
Jaklin M et al (2022) Optimization of the TeraTox assay for preclinical teratogenicity assessment. Toxicol Sci 188(1):17–33. https://doi.org/10.1093/toxsci/kfac046
Gamble JT, Hopperstad K, Deisenroth C (2022) The DevTox germ layer reporter platform: an assay adaptation of the human pluripotent stem cell test. Toxics 10(7):1–24. https://doi.org/10.3390/toxics10070392
Witt G et al (2021) An automated and high-throughput-screening compatible pluripotent stem cell-based test platform for developmental and reproductive toxicity assessment of small molecule compounds. Cell Biol Toxicol 37(2):229–243. https://doi.org/10.1007/s10565-020-09538-0
Lauschke K et al (2020) A novel human pluripotent stem cell-based assay to predict developmental toxicity. Arch Toxicol 94(11):3831–3846. https://doi.org/10.1007/s00204-020-02856-6
Acknowledgments
The authors want to acknowledge and express gratitude toward our guide Dr. Satarupa Banerjee (SBST, VIT Vellore) and our fellow PhD scholars for constantly guiding us and the staff and management of VIT Vellore for providing us the opportunity to carry our study.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Banerjee, M., Das, A., Chatterjee, P., Banerjee, S. (2024). Human Pluripotent Stem Cell-Based Assays to Predict Developmental Toxicity. In: FĂ©lix, L. (eds) Teratogenicity Testing. Methods in Molecular Biology, vol 2753. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3625-1_8
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3625-1_8
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3624-4
Online ISBN: 978-1-0716-3625-1
eBook Packages: Springer Protocols